According to the findings of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Centre, adding an immunomodulatory agent to treatment with the targeted tyrosine kinase inhibitor (TKI) cediranib did not improve outcomes in patients with differ
Aggressive and relatively common lymphomas called diffuse large B cell lymphomas (DLBCLs) have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves, according to a study from researchers at Weill Cornell Medicine and Cornell's Ithaca campus
New York [US], January 21 (ANI): A new study has found that to stop acute myeloid leukaemia, one of the deadliest blood cancers, targeting neighbouring bone cells may be a better strategy.
Washington [US], January 9 (ANI): According to a study from researchers at Weill Cornell Medicine and Cornell's Ithaca campus, aggressive and relatively common lymphomas called diffuse large B cell lymphomas (DLBCLs) have a critical metabolic vulnerability that can be exploited to trick thes
Washington [US], January 4 (ANI): Aggressive and relatively common lymphomas called diffuse large B cell lymphomas (DLBCLs) have a critical metabolic vulnerability that can be exploited to trick these cancers into starving themselves, according to a study from researchers at Weill Cornell Me
Washington D.C, Jul 11 (ANI): A team of researchers has brought fresh hope in the form of a new treatment target for ovarian cancer aka "the silent killer."